Experiments in both prostate and breast cancer cell lines revealed increased Programmed death-ligand 1 (PD-L1) expression via increased HIF1α expression and subsequent binding at HREs in the PD-L1 promoter in hypoxic (0.5% O2) versus normoxic (20% O2) conditions. Here, HIF1A is linked to breast cancer.